Multicenter Clinical Evaluation of ETEST Plazomicin (PLZ) for Susceptibility Testing of Enterobacterales.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
19 01 2022
Historique:
pubmed: 11 11 2021
medline: 16 3 2022
entrez: 10 11 2021
Statut: ppublish

Résumé

Plazomicin (PLZ), brand name ZEMDRI (Cipla Therapeutics), is a novel aminoglycoside antibiotic approved by the U.S. Food and Drug Administration (FDA) for treatment of complicated urinary tract infections including pyelonephritis. ETEST® is a gradient diffusion method that represents an alternative to the more laborious broth micro-dilution (BMD) method for performing antimicrobial susceptibility testing (AST). A multi-center evaluation of the performance of the new ETEST PLZ (bioMérieux) was conducted in comparison with BMD following FDA and International Standards Organization (ISO) recommendations using FDA-defined breakpoints. Clinical isolates of Enterobacterales (

Identifiants

pubmed: 34757833
doi: 10.1128/JCM.01831-21
pmc: PMC8769719
doi:

Substances chimiques

Anti-Bacterial Agents 0
plazomicin LYO9XZ250J
Sisomicin X55XSL74YQ

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0183121

Références

Expert Rev Anti Infect Ther. 2020 Aug;18(8):705-720
pubmed: 32319833
Antimicrob Agents Chemother. 2020 Apr 21;64(5):
pubmed: 32152078
N Engl J Med. 2019 Feb 21;380(8):791-793
pubmed: 30786196
Diagn Microbiol Infect Dis. 2020 Aug;97(4):115092
pubmed: 32569921
Infect Dis Clin North Am. 2016 Jun;30(2):523-537
pubmed: 27208771
J Antimicrob Chemother. 2018 Dec 1;73(12):3346-3354
pubmed: 30219857
Open Forum Infect Dis. 2019 Mar 12;6(4):ofz123
pubmed: 30968059
Diagn Microbiol Infect Dis. 2020 Oct;98(2):115117
pubmed: 32755805
Antimicrob Agents Chemother. 2020 Apr 21;64(5):
pubmed: 32094137
Expert Opin Investig Drugs. 2015;24(11):1501-11
pubmed: 26419762
Microbiome. 2020 Mar 20;8(1):41
pubmed: 32197644
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115239
pubmed: 33130509
Clin Ther. 2019 Aug;41(8):1453-1462
pubmed: 31248681
Curr Infect Dis Rep. 2020 Feb 7;22(3):6
pubmed: 32034524
Ther Adv Infect Dis. 2020 Sep 4;7:2049936120952604
pubmed: 32953108
ACS Infect Dis. 2018 Jun 8;4(6):980-987
pubmed: 29634241
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):461-475
pubmed: 33009595
J Glob Antimicrob Resist. 2021 Mar;24:183-189
pubmed: 33373732

Auteurs

Laurine S Blanchard (LS)

bioMérieux SA, Marcy l'Etoile, France.

Alex Van Belkum (A)

bioMérieux, SA., La Balme-les-Grottes, France.

Dominique Dechaume (D)

bioMérieux, SA., La Balme-les-Grottes, France.

Thomas P Armstrong (TP)

bioMérieux Inc., Hazelwood, Missouri, USA.

Christopher L Emery (CL)

Indiana University School of Medicine, Indianapolis, Indiana, USA.

Yun X Ying (YX)

Quest Diagnostics, Lewisville, Texas, USA.

Michael Kresken (M)

Antiinfectives Intelligence GmbH, Cologne, Germany.

Marion Pompilio (M)

bioMérieux, SA., La Balme-les-Grottes, France.

Diane Halimi (D)

bioMérieux, SA., La Balme-les-Grottes, France.

Gilles Zambardi (G)

bioMérieux, SA., La Balme-les-Grottes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH